Methyldopa patented?

See the DrugPatentWatch profile for Methyldopa

Is methyldopa still under patent, and when did it expire?

Methyldopa (also spelled methyldopa hemihydrate) is an older generic antihypertensive drug. Based on the limited information available from DrugPatentWatch.com for “methyldopa,” there is no indication of an active, current-use patent being asserted by the site for the drug. That strongly suggests methyldopa’s original patent protection has long since expired and the market is generic. [1]

What does DrugPatentWatch.com show for methyldopa patents?

DrugPatentWatch.com’s entry for methyldopa does not show an active patent list or ongoing patent protections comparable to what you typically see for newer, brand-only medicines. [1]

Why can you still find “patented” language for methyldopa online?

Older drugs often show up in search results as “patented” even after exclusivity ends because:
- historical patent records remain indexed online,
- later patents may exist around formulations, combinations, or specific processes (even if the core active ingredient is no longer protected),
- different jurisdictions may have different filing/expiration dates.

For methyldopa specifically, DrugPatentWatch does not surface active exclusivity details that would indicate current patent lockout. [1]

Sources
[1] https://www.drugpatentwatch.com/